| Name | Title | Contact Details |
|---|
Alive Hospice has been offering loving care to people with life-threatening illnesses, support to their families and service to the community in a spirit of enriching lives since 1975. As the oldest community-based hospice in Middle Tennessee, we
Front Range Cancer Specialists is a Fort Collins, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hallman Group is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dornier MedTech, a wholly-owned subsidiary of Accuron Medical Technology group with manufacturing headquarters in Munich, Germany, is a medical device company known for its pioneering technologies and revolutionary therapies in urology. Dornier MedTech soars thanks to its deep rooted spirit of entrepreneurship, excellence and innovation while developing some of the highest quality urology products on the market today.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.